Insights

Q2 2026 Drug Updates: New FDA Approvals, Generics and Biosimilars to Watch 

Learn More

Your PBM Contract Has Fine Print. The Fine Print Is Where the Money Is.

Learn More

What Plan Sponsors Need to Know About HIV Treatment, PrEP and Pharmacy Costs

Learn More

Everyone’s Talking About Pharmacogenomics. The Hard Part Is Making It Work 

Learn More

GLP-1 Market Update: Oral Drugs, New Formulations, Pipeline Activity, and Pricing Shifts 

Learn More

International Drug Sourcing Is Under Scrutiny. What Employers Should Understand Before Adopting It 

Learn More

Direct-to-Consumer (DTC) Prescription Drug Programs 

Learn More

Filter Insights:

Join our newsletter to stay up to date on market trends.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Latest Insights

Q3 2026 Drug Updates: New FDA Approvals, Generics and Biosimilars to Watch 

OnPoint-Light-Dark 2

A Navion Video Series

Welcome to On Point with Navion. In five minutes or less, we’ll break down what’s happening in pharmacy, what it means for your groups, and what to do next. No fluff, just what you need to know every month.

GET STARTED

Experience Navion in action with a savings analysis!

Our custom Rx savings analysis delivers a side by-side assessment to ensure your groups have a single source of truth to choose the PBM option that’s right for them.